|
|
|||
|
|||
|
|
|||
|
infant food allergies |
|||
|
|
|||
|
|||
 
|
|||
|
|
|||
|
infant food allergies DESCRIPTION Zafirlukast is a synthetic, selective peptide leukotriene receptor antagonist(LTRA), with the chemical name 4-(5-cyclopentyloxy-carbonylamino-1-methyl-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide infant food allergies. The molecular weight of zafirlukast is 575.7 and the structural formula is:
Zafirlukast, a fine white to pale yellow amorphous powder, is practically insolublein water infant food allergies. It is slightly soluble in methanol and freely soluble in tetrahydrofuran,dimethylsulfoxide, and acetone infant food allergies. ACCOLATE is supplied as 10 and 20 mg tablets for oral administration infant food allergies. Inactive Ingredients: Film-coated tablets containing croscarmellose sodium,lactose, magnesium stearate, microcrystalline cellulose, povidone, hypromellose,and titanium dioxide infant food allergies.
In vitro studies demonstrated that zafirlukast antagonized the contractileactivity of three leukotrienes (LTC 4 , LTD 4 and LTE 4 ) in conducting airwaysmooth muscle from laboratory animals and humans infant food allergies. Zafirlukast prevented intradermalLTD 4 -induced increases in cutaneous vascular permeability and inhibited inhaledLTD 4 -induced influx of eosinophils into animal lungs infant food allergies. Inhalational challengestudies in sensitized sheep showed that zafirlukast suppressed the airway responsesto antigen; this included both the early- and late-phase response and the nonspecifichyperresponsiveness infant food allergies. In humans, zafirlukast inhibited bronchoconstriction caused by several kindsof inhalational challenges infant food allergies. Pretreatment with single oral doses of zafirlukastinhibited the bronchoconstriction caused by sulfur dioxide and cold air in patientswith asthma infant food allergies. Pretreatment with single doses of zafirlukast attenuated the early-and late-phase reaction caused by inhalation of various antigens such as grass,cat dander, ragweed, and mixed antigens in patients with asthma infant food allergies. Zafirlukastalso attenuated the increase in bronchial hyperresponsiveness to inhaled histaminethat followed inhaled allergen challenge infant food allergies. Clinical Pharmacokinetics and Bioavailability: Distribution Metabolism Excretion In the pivotal bioequivalence study, the mean terminal half-life of zafirlukastis approximately 10 hours in both normal adult subjects and patients with asthma infant food allergies. In other studies, the mean plasma half-life of zafirlukast ranged from approximately8 to 16 hours in both normal subjects and patients with asthma infant food allergies. The pharmacokineticsof zafirlukast are approximately linear over the range from 5 mg to 80 mg infant food allergies. Steady-stateplasma concentrations of zafirlukast are proportional to the dose and predictablefrom single-dose pharmacokinetic data infant food allergies. Accumulation of zafirlukast in the plasmafollowing twice-daily dosing is approximately 45% infant food allergies. The pharmacokinetic parameters of zafirlukast 20 mg administered as a singledose to 36 male volunteers are shown with the table below infant food allergies. Mean (% Coefficient of Variation) pharmacokinetic
Race: No differences in the pharmacokinetics of zafirlukast due to race havebeen observed infant food allergies. Elderly: The apparent oral clearance of zafirlukast decreases with age infant food allergies. Inpatients above 65 years of age, there is an approximately 2-3 fold greater Cmax and AUC compared to young adult patients infant food allergies. Children: Following administration of a single 20 mg dose of zafirlukast to20 boys and girls between 7 and 11 years of age, and in a second study, to 29boys and girls between 5 and 6 years of age, the following pharmacokinetic parameterswere obtained: Parameter Children age
Zafirlukast disposition was unchanged after multiple dosing (20 mg twice daily)in children and the degree of accumulation in plasma was similar to that observedin adults infant food allergies. Hepatic Insufficiency: In a study of patients with hepatic impairment (biopsy-provencirrhosis), there was a reduced clearance of zafirlukast resulting in a 50-60%greater C max and AUC compared to normal subjects infant food allergies. Renal Insufficiency: Based on a cross-study comparison, there are no apparentdifferences in the pharmacokinetics of zafirlukast between renally-impairedpatients and normal subjects infant food allergies. Drug-Drug Interactions
|
|||
 
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
| iinfant food allergies innfant food allergies inffant food allergies infaant food allergies infannt food allergies infantt food allergies infant food allergies infant ffood allergies infant foood allergies infant foood allergies infant foodd allergies infant food allergies infant food aallergies infant food alllergies infant food alllergies infant food alleergies infant food allerrgies infant food allerggies infant food allergiies infant food allergiees infant food allergiess nfant food allergies ifant food allergies inant food allergies infnt food allergies infat food allergies infan food allergies infantfood allergies infant ood allergies infant fod allergies infant fod allergies infant foo allergies infant foodallergies infant food llergies infant food alergies infant food alergies infant food allrgies infant food allegies infant food alleries infant food allerges infant food allergis infant food allergie i nfant food allergies in fant food allergies inf ant food allergies infa nt food allergies infan t food allergies infant food allergies infant food allergies infant f ood allergies infant fo od allergies infant foo d allergies infant food allergies infant food allergies infant food a llergies infant food al lergies infant food all ergies infant food alle rgies infant food aller gies infant food allerg ies infant food allergi es infant food allergie s infant food allergies nifant food allergies ifnant food allergies inafnt food allergies infnat food allergies infatn food allergies infan tfood allergies infantf ood allergies infant ofod allergies infant food allergies infant fodo allergies infant foo dallergies infant fooda llergies infant food lalergies infant food allergies infant food alelrgies infant food allregies infant food allegries infant food alleriges infant food allergeis infant food allergise ainfant food allergies theinfant food allergies infant food allergies | |||
|
|
|||
|
|
|||
|
|
|||
|
Copyright 2005 D-S LTD. |
